MIST Milestone Pharmaceuticals Inc. - Common Shares
$1.44
가격 · 5월 20, 2026
기준 재무 정보 5월 13, 2026
52주 범위
$1–$3
21% of range
애널리스트 평점
BUY
12 analysts
목표 주가
$6
+340% upside
P/E (TTM)
-2.7
ROE
-525.0%
순이익률
—
MIST 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$1.44
시가총액
$215M
P/E (TTM)
-2.7
EPS (TTM)
$-0.75
매출 (TTM)
—
배당 수익률
—
ROE
-525.0%
부채/자본
—
52주 범위
$1 – $3
MIST 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-0.75
2020-12-31
→
2025-12-31
잉여현금흐름
$-49M
2019-12-31
→
2025-12-31
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
MIST
동종업계 중앙값
P/E (TTM)
-2.7
—
P/B
5.1
0.5
Price / FCF (주가 / FCF)
-4.3
—
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
MIST
동종업계 중앙값
ROA
-66.7%
-73.1%
ROE
-525.0%
-92.8%
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
MIST
동종업계 중앙값
Current Ratio (유동비율)
8.0
4.8
Quick Ratio (당좌 비율)
7.6
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
MIST
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
MIST
동종업계 중앙값
MIST 분석가 합의 강세 및 약세 애널리스트 의견, 12개월 목표 주가, 상승 여력
매수
12 명의 애널리스트
- 적극 매수 3 25.0%
- 매수 7 58.3%
- 보유 2 16.7%
- 매도 0 0.0%
- 적극 매도 0 0.0%
12개월 목표 주가
6 명의 애널리스트 · 2026-05-18
중앙값
$7.00
평균
$6.33
← 모든 목표가 하회
$1.44
저가
$2.00
고가
$8.00
중앙값 목표
$7.00
+386.1%
평균 목표
$6.33
+339.8%
실적 기록 EPS 실제 vs 예상, 서프라이즈 %, 달성률, 다음 실적 발표일
평균 서프라이즈
-0.11%
| 기간 | EPS Actual | EPS 예상 | 서프라이즈 |
|---|---|---|---|
| 2026년 3월 31일 | $-0.20 | $0.31 | -0.51% |
| 2025년 12월 31일 | $-0.18 | $-0.16 | -0.02% |
| 2025년 9월 30일 | $-0.12 | $-0.17 | 0.05% |
| 2025년 6월 30일 | $-0.20 | $-0.18 | -0.02% |
| 2025년 3월 31일 | $-0.31 | $-0.19 | -0.12% |
| 2024년 12월 31일 | $-0.20 | $-0.16 | -0.04% |
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $14M | $31M | $40M | $39M | $34M | $42M | $17M | |
| SG&A Expense | $17M | $17M | $16M | $16M | $12M | $10M | $7M | $3M | |
| Operating Income | $-62M | $-42M | $-61M | $-60M | $-43M | $-51M | $-58M | $-24M | |
| Interest Expense | · | · | $3M | · | · | · | · | · | |
| Interest Income | $3M | $4M | $4M | · | · | · | · | · | |
| Pretax Income | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | $-23M | |
| Income Tax | · | · | · | · | · | $-17.0K | $-56.0K | $74.0K | |
| Net Income | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | $-23M | |
| EPS (Basic) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | · | · | |
| EPS (Diluted) | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 | $-1.70 | · | · | |
| EBITDA | $-62M | $-42M | · | · | $-43M | $-51M | $-58M | · |
대차대조표 22
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $73M | $25M | $14M | $8M | $114M | $72M | $120M | $86M | |
| Short-term Investments | $33M | $44M | $52M | $57M | $0 | $70M | · | $29.0K | |
| Inventory | $648.0K | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $2M | $3M | $6M | $4M | $5M | $2M | $1M | |
| Current Assets | $112M | $74M | $73M | $72M | $119M | $149M | $122M | $88M | |
| PP&E (Net) | $511.0K | $197.0K | $277.0K | $257.0K | $215.0K | $308.0K | $405.0K | $30.0K | |
| PP&E (Gross) | $917.0K | $488.0K | $468.0K | $377.0K | $454.0K | $454.0K | $454.0K | $41.0K | |
| Accum. Depreciation | $406.0K | $291.0K | $191.0K | $120.0K | $239.0K | $146.0K | $49.0K | $11.0K | |
| Total Assets | $114M | $75M | $75M | $74M | $120M | $150M | $123M | $88M | |
| Accounts Payable | $6M | $8M | $7M | $6M | $7M | $6M | $8M | $4M | |
| Accrued Liabilities | $8M | · | · | · | · | · | · | · | |
| Current Liabilities | $14M | $8M | $7M | $6M | $7M | $6M | $8M | $5M | |
| Capital Leases | $539.0K | $874.0K | $1M | $2M | $474.0K | $696.0K | $184.0K | · | |
| Other Non-current Liabilities | $83.0K | · | · | · | · | · | · | · | |
| Total Liabilities | $72M | $62M | $58M | $8M | $7M | $7M | $9M | $5M | |
| Long-term Debt | $57M | $53M | $50M | · | · | · | $0 | · | |
| Common Stock | $353M | $288M | $261M | $274M | $252M | $252M | $226M | $2M | |
| Paid-in Capital | $64M | $40M | $34M | $24M | $16M | $9M | $4M | $3M | |
| Retained Earnings | $-431M | $-368M | $-326M | $-266M | $-208M | $-163M | $-113M | $-58M | |
| Stockholders' Equity | $42M | $13M | $17M | $66M | $113M | $143M | $115M | $84M | |
| Liabilities + Equity | $114M | $75M | $75M | $74M | $120M | $150M | $123M | $88M | |
| Shares Outstanding | 106,236,344 | 53,353,984 | 33,483,111 | 34,286,002 | 29,897,559 | 29,827,997 | 24,505,748 | 596,787 |
현금 흐름 11
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $114.0K | $105.0K | $92.0K | $89.0K | $93.0K | $97.0K | $38.0K | $10.0K | |
| Stock-based Comp | $7M | $6M | $10M | $9M | $7M | $5M | $1M | $633.0K | |
| Other Non-cash | $6M | $7M | · | · | $2M | $-6M | $3M | · | |
| Operating Cash Flow | $-49M | $-29M | $-46M | $-52M | $-33M | $-51M | $-51M | $-21M | |
| CapEx | $302.0K | $33.0K | $112.0K | $272.0K | · | · | $413.0K | $5.0K | |
| Investing Cash Flow | $11M | $8M | $5M | $-57M | $70M | $-70M | $-384.0K | $16M | |
| Stock Issued | $38M | $27M | · | $3M | · | $25M | · | · | |
| Net Stock Activity | $38M | $27M | · | · | · | $25M | · | · | |
| Financing Cash Flow | $86M | $32M | $48M | $3M | $5M | $73M | $85M | $80M | |
| Net Change in Cash | $48M | $12M | $6M | $-107M | $42M | $-48M | $34M | $75M | |
| Free Cash Flow | $-49M | $-29M | · | · | · | · | $-52M | · |
수익성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -66.7% | -55.1% | · | · | -31.8% | -36.5% | -52.2% | · | |
| ROE | -525.0% | -223.5% | · | · | -35.7% | -40.7% | -44.6% | · | |
| ROIC | · | · | · | · | · | -35.4% | -50.3% | · |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 8.0 | 9.1 | · | · | 17.6 | 24.1 | 14.7 | · | |
| Quick Ratio | 7.6 | 8.6 | · | · | 16.8 | 23.1 | 14.4 | · |
가치 평가 (TTM) 8
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-63M | $-42M | $-60M | $-58M | $-43M | $-50M | $-55M | · | |
| Market Cap | $215M | $126M | · | · | $196M | $200M | $392M | · | |
| P/E | -2.7 | -3.5 | -1.2 | -2.9 | -6.4 | -3.9 | · | · | |
| P/B | 5.1 | 9.6 | · | · | 1.7 | 1.4 | 3.4 | · | |
| P / Tangible Book | 5.1 | 9.6 | 3.3 | 2.0 | 1.7 | 1.4 | · | · | |
| P / Cash Flow | -4.4 | -4.4 | · | · | -5.9 | -3.9 | -7.7 | · | |
| P / FCF | -4.3 | -4.4 | · | · | · | · | -7.6 | · | |
| Earnings Yield | -37.1% | -28.4% | -83.2% | -34.8% | -15.6% | -25.4% | · | · |
손익계산서 11
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| Revenue | $238.0K | |
| Cost of Revenue | $14.0K | |
| R&D Expense | $3M | |
| SG&A Expense | $5M | |
| Operating Expenses | $24M | |
| Operating Income | $-24M | |
| Interest Income | $2M | |
| Net Income | $-26M | |
| EPS (Basic) | $-0.20 | |
| EPS (Diluted) | $-0.20 | |
| EBITDA | $-24M |
대차대조표 21
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $71M | |
| Short-term Investments | $113M | |
| Receivables | $2M | |
| Inventory | $2M | |
| Prepaid Expense | $1M | |
| Current Assets | $192M | |
| PP&E (Net) | $500.0K | |
| Total Assets | $194M | |
| Accounts Payable | $10M | |
| Accrued Liabilities | $10M | |
| Current Liabilities | $21M | |
| Capital Leases | $366.0K | |
| Other Non-current Liabilities | $72.0K | |
| Total Liabilities | $158M | |
| Long-term Debt | $58M | |
| Common Stock | $374M | |
| Paid-in Capital | $63M | |
| Retained Earnings | $-457M | |
| Stockholders' Equity | $36M | |
| Liabilities + Equity | $194M | |
| Shares Outstanding | 117,794,417 |
현금 흐름 11
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| D&A | $56.0K | |
| Stock-based Comp | $1M | |
| Other Non-cash | $9M | |
| Operating Cash Flow | $-16M | |
| CapEx | $45.0K | |
| Investing Cash Flow | $-80M | |
| Stock Issued | $11M | |
| Net Stock Activity | $11M | |
| Financing Cash Flow | $94M | |
| Net Change in Cash | $-2M | |
| Free Cash Flow | $-16M |
수익성 5
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| Operating Margin | -9942.4% | |
| Net Margin | -10952.1% | |
| EBITDA Margin | -9918.9% | |
| ROA | -20.4% | |
| ROE | -174.2% |
유동성 및 지급능력 2
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| Current Ratio | 9.2 | |
| Quick Ratio | 8.9 |
효율성 3
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| Asset Turnover | 0.0 | |
| Inventory Turnover | 0.0 | |
| Receivables Turnover | 0.3 |
가치 평가 (TTM) 8
| 지표 | 추세 | Q1 2026 |
|---|---|---|
| Net Income TTM | $-72M | |
| Market Cap | $140M | |
| P/E | -1.4 | |
| P/B | 3.9 | |
| P / Tangible Book | 3.9 | |
| P / Cash Flow | -8.7 | |
| P / FCF | -8.7 | |
| Earnings Yield | -69.8% |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-63M | $-42M | $-60M | $-58M | $-43M |
| 희석 EPS | $-0.75 | $-0.67 | $-1.39 | $-1.38 | $-1.02 |
대차대조표
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 8.0 | 9.1 | — | — | 17.6 |
| 당좌 비율 | 7.6 | 8.6 | — | — | 16.8 |
현금 흐름
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| 잉여현금흐름 | $-49M | $-29M | — | — | — |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.